Cargando…

Managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the UK

Microbial resistance to antibiotics is a serious global health problem compounded by antibiotic overuse and limited investment in new antibiotic research. Inappropriate perinatal antibiotic exposure is increasingly linked to lifelong adverse outcomes through its impact on the developing microbiome....

Descripción completa

Detalles Bibliográficos
Autores principales: Makri, Vasiliki, Davies, Gemma, Cannell, Stephanie, Willson, Katherine, Winterson, Lucy, Webb, Joanna, Kandhari, Amit, Mansour, Maha, Thomas, Joanne, Morris, Geraint, Matthes, Jean, Banerjee, Sujoy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942449/
https://www.ncbi.nlm.nih.gov/pubmed/29756072
http://dx.doi.org/10.1136/bmjoq-2017-000285
_version_ 1783321473840054272
author Makri, Vasiliki
Davies, Gemma
Cannell, Stephanie
Willson, Katherine
Winterson, Lucy
Webb, Joanna
Kandhari, Amit
Mansour, Maha
Thomas, Joanne
Morris, Geraint
Matthes, Jean
Banerjee, Sujoy
author_facet Makri, Vasiliki
Davies, Gemma
Cannell, Stephanie
Willson, Katherine
Winterson, Lucy
Webb, Joanna
Kandhari, Amit
Mansour, Maha
Thomas, Joanne
Morris, Geraint
Matthes, Jean
Banerjee, Sujoy
author_sort Makri, Vasiliki
collection PubMed
description Microbial resistance to antibiotics is a serious global health problem compounded by antibiotic overuse and limited investment in new antibiotic research. Inappropriate perinatal antibiotic exposure is increasingly linked to lifelong adverse outcomes through its impact on the developing microbiome. Antibiotic stewardship may be the only effective preventative strategy currently available. As the first tertiary neonatal unit in the UK to collaborate in an international quality improvement programme (QIP) with Vermont Oxford Network (VON), we present the results of our antibiotic stewardship initiative. The QIP was officially launched in January 2016 and aimed to reduce antibiotic usage rate (AUR) by 20% of baseline by 31st December 2016 without compromising patient safety. A multidisciplinary team of professionals and parent representatives shared good practices and improvement strategies through international webinars and local meetings, devised uniform data collection methodology and implemented a number of carefully selected ‘Plan–Do–Study–Act’ cycles. Run charts were used to present data and, where appropriate, statistical analysis undertaken to compare outcomes. The QIP resulted in a sustained reduction in AUR from a baseline median of 347 to 198 per 1000 patient-days (a reduction of 43%). The proportion of culture-negative sepsis screens where antibiotics were stopped within 36–48 hours increased consistently from a baseline of 32.5% to 91%. The antibiotic days per patient at discharge reduced from a median of 3 to 2 days, and there was a reduction in practice variation. Our annual mortality and necrotising enterocolitis rates for the VON cohort (<30 weeks or <1500 g) were the best ever recorded, 5.5% and 1.4%, respectively. Audits confirmed a high level of staff and family awareness of the QIP. The QIP achieved a sustained reduction in antibiotic use without compromising patient safety. Our challenge is to sustain this improvement safely.
format Online
Article
Text
id pubmed-5942449
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-59424492018-05-11 Managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the UK Makri, Vasiliki Davies, Gemma Cannell, Stephanie Willson, Katherine Winterson, Lucy Webb, Joanna Kandhari, Amit Mansour, Maha Thomas, Joanne Morris, Geraint Matthes, Jean Banerjee, Sujoy BMJ Open Qual BMJ Quality Improvement report Microbial resistance to antibiotics is a serious global health problem compounded by antibiotic overuse and limited investment in new antibiotic research. Inappropriate perinatal antibiotic exposure is increasingly linked to lifelong adverse outcomes through its impact on the developing microbiome. Antibiotic stewardship may be the only effective preventative strategy currently available. As the first tertiary neonatal unit in the UK to collaborate in an international quality improvement programme (QIP) with Vermont Oxford Network (VON), we present the results of our antibiotic stewardship initiative. The QIP was officially launched in January 2016 and aimed to reduce antibiotic usage rate (AUR) by 20% of baseline by 31st December 2016 without compromising patient safety. A multidisciplinary team of professionals and parent representatives shared good practices and improvement strategies through international webinars and local meetings, devised uniform data collection methodology and implemented a number of carefully selected ‘Plan–Do–Study–Act’ cycles. Run charts were used to present data and, where appropriate, statistical analysis undertaken to compare outcomes. The QIP resulted in a sustained reduction in AUR from a baseline median of 347 to 198 per 1000 patient-days (a reduction of 43%). The proportion of culture-negative sepsis screens where antibiotics were stopped within 36–48 hours increased consistently from a baseline of 32.5% to 91%. The antibiotic days per patient at discharge reduced from a median of 3 to 2 days, and there was a reduction in practice variation. Our annual mortality and necrotising enterocolitis rates for the VON cohort (<30 weeks or <1500 g) were the best ever recorded, 5.5% and 1.4%, respectively. Audits confirmed a high level of staff and family awareness of the QIP. The QIP achieved a sustained reduction in antibiotic use without compromising patient safety. Our challenge is to sustain this improvement safely. BMJ Publishing Group 2018-05-07 /pmc/articles/PMC5942449/ /pubmed/29756072 http://dx.doi.org/10.1136/bmjoq-2017-000285 Text en © Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle BMJ Quality Improvement report
Makri, Vasiliki
Davies, Gemma
Cannell, Stephanie
Willson, Katherine
Winterson, Lucy
Webb, Joanna
Kandhari, Amit
Mansour, Maha
Thomas, Joanne
Morris, Geraint
Matthes, Jean
Banerjee, Sujoy
Managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the UK
title Managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the UK
title_full Managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the UK
title_fullStr Managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the UK
title_full_unstemmed Managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the UK
title_short Managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the UK
title_sort managing antibiotics wisely: a quality improvement programme in a tertiary neonatal unit in the uk
topic BMJ Quality Improvement report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5942449/
https://www.ncbi.nlm.nih.gov/pubmed/29756072
http://dx.doi.org/10.1136/bmjoq-2017-000285
work_keys_str_mv AT makrivasiliki managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk
AT daviesgemma managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk
AT cannellstephanie managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk
AT willsonkatherine managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk
AT wintersonlucy managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk
AT webbjoanna managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk
AT kandhariamit managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk
AT mansourmaha managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk
AT thomasjoanne managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk
AT morrisgeraint managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk
AT matthesjean managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk
AT banerjeesujoy managingantibioticswiselyaqualityimprovementprogrammeinatertiaryneonatalunitintheuk